Browsing eNauka

Browsing by Author Van, Vollenhoven Ronald

Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)TypeМp-cat.
2020Efficacy and Safety of Iberdomide in Patients with Active Systemic Lupus Erythematosus: 24-Week Results of a Phase 2, Randomized, Placebo-Controlled StudyMerrill, Joan T; Werth, Victoria; Furie, Richard; Van, Vollenhoven Ronald; Petronijević, Milan R  ; Velasco, Zamora Benito; Majdan, Maria; Irazoque-Palazuelos, Fedra; Weiswasser, Michael; Korish, Shimon;
Schafer, Peter; Liu, Zhaohui; Gaudy, Allison; Agafonova, Nataliya; Delev, Nikolay;
Conference Paper
Mp. category will be shown later
2019The Association Between Patient Reported Outcomes and Clinical Measures Among Rheumatoid Arthritis Patients: Analyses Using Phase 3 Clinical Trials of UpadacitinibStrand, Vibeke; Damjanov, Nemanja S; Scoville, Craig; Tundia, Namita; Camp, Heidi S; Chen, Kun; Suboticki, Jessica L; Van, Vollenhoven RonaldConference Paper
Mp. category will be shown later
2018The Association between Patient Reported Outcomes and Clinical Measures Among Rheumatoid Arthritis Patients: Analyses Using Phase 3 Clinical Trials of UpadacitinibStrand, Vibeke; Damjanov, Nemanja S; Scoville, Craig; Tundia, Namita; Camp, Heidi S; Chen, Kun; Suboticki, Jessica L; Van, Vollenhoven RonaldConference Paper
Mp. category will be shown later
2019The Impact of Upadacitinib versus Methotrexate or Adalimumab on Individual and Composite Disease Measures in Patients with Rheumatoid ArthritisVan, Vollenhoven Ronald; Ostor, Andrew; Mysler, Eduardo; Damjanov, Nemanja S; Song, In-Ho; Song, Yanna; Suboticki, Jessica; Strand, VibekeConference Paper
Mp. category will be shown later
2020The Impact of Upadacitinib Versus Methotrexate Or Adalimumab on Individual and Composite Disease Measures in Patients with Rheumatoid ArthritisVan, Vollenhoven Ronald; Ostor, Andrew; Mysler, Eduardo; Damjanov, Nemanja S; Song, In-Ho; Song, Yanna; Suboticki, Jessica; Strand, VibekeConference Paper
Mp. category will be shown later